BSN169

Identifiers: BioSample: SAMN38637749; Sample name: Staphylococcus aureus str BSN169; SRA: SRS20736298

Organism: Staphylococcus aureus
cellular organisms; Bacteria; Bacillati; Bacillota; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus

Attributes

collection date	2021-11-20
strain	BSN169
collected by	Andrew D. Berti
geographic location	USA: Detroit, MI
host	Homo sapiens
host disease	acute hypoxic respiratory failure
isolation source	blood
latitude and longitude	42.33 N 83.05 W
genotype	ST105-MRSA-II CC5
host age	73
host description	Patient with chronic encephalopathy presents on transfer from outside hospital with mental status changes and a displaced epigastric tube. Blood cultures grew methicillin-resistant Staphylococcus aureus managed with vancomycin. Clinical course was complicated by severe calorie malnution, septic versus cardiogenic shock, tension pneumothorax, acute hypoxic respiratory failure requiring emergent intubation and pressor support and bilateral deep vein thromboses in the setting of low hemoglobin. Patient developed coagulopathies, acute kidney injury and remained hypotensive on triple pressor therapy. Patient developed pulseless electrical activity and expired. Duration of bacteremia: 4 days.
host disease outcome	death
host sex	female
host subject id	BSS169
methicillin susceptibility	resistant
Ridom spa type	t002
Kreiswirth spa type	TJMBMDMGMK
Alternate Nomenclature	B0848
Other Isolates from Patient	none
Provenance	Detroit Medical Center > Berti

BioProject: PRJNA1048360 Staphylococcus aureus
Retrieve all samples from this project

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
clindamycin	resistant	>	2	mg/L	MIC	Phoenix	Becton Dickinson		CLSI
daptomycin	susceptible	<=	1	mg/L	MIC	Phoenix	Becton Dickinson		CLSI
erythromycin	resistant	>	4	mg/L	MIC	Phoenix	Becton Dickinson		CLSI
gentamicin	resistant	>	8	mg/L	MIC	Phoenix	Becton Dickinson		CLSI
linezolid	susceptible	<=	1	mg/L	MIC	Phoenix	Becton Dickinson		CLSI
oxacillin	resistant	>	2	mg/L	MIC	Phoenix	Becton Dickinson		CLSI
rifampin	susceptible	<=	0.5	mg/L	MIC	Phoenix	Becton Dickinson		CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	0.5/9.5	mg/L	MIC	Phoenix	Becton Dickinson		CLSI
vancomycin	susceptible	==	1	mg/L	MIC	Phoenix	Becton Dickinson		CLSI
vancomycin	susceptible	==	1	mg/L	MIC		Biomérieux	E-Test	CLSI

BioSample